COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Spectranetics Corporation (NASDAQ: SPNC) has received notice from the Staff of the NASDAQ Stock Market stating that, as previously disclosed in a Form 8-K filing with the Securities and Exchange Commission, due to the appointment of Emile J. Geisenheimer, formerly an independent director and audit committee member, as the Company’s President and Chief Executive Officer, the Company was not in compliance with NASDAQ’s independent director and audit committee requirements as set forth in NASDAQ Marketplace Rule 4350. As previously disclosed, the Company intends to be in compliance with NASDAQ Marketplace Rule 4350 within the cure period, and no later than the earlier of the Company’s next annual shareholders’ meeting or October 21, 2009, or no later than April 20, 2009 if the next annual shareholders’ meeting is held before April 20, 2009.
